DOCSLIB.ORG

PROGRAM and PROCEEDINGS Dr. Fredric W. Scott

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PROGRAM and PROCEEDINGS Dr. Fredric W. Scott PROGRAM and PROCEEDINGS of the 94th Annual Meeting December 8, 9 and 10, 2013 Marriott, Downtown Magnificent Mile Chicago, Illinois Robert P. Ellis, Executive Editor http://www.cvmbs.colostate.edu/mip/crwad/ The 94th Annual Meeting of the CRWAD is dedicated to Dr. Fredric W. Scott Proceedings Distributed by CRWAD CRWAD 94th ANNUAL MEETING-2013 December 8 – 10, 2013 All attendees and presenters are required to wear their name badges at all times. Registration - 5th Floor Registration Booth Sunday 10 AM - 5:30 PM Monday 7:00 AM - Noon, 2 - 5 PM Tuesday 8 - 11 AM Researchers Reception - Welcome all attendees. Casual Wear Sunday, December 8, 6-8 PM – Grand Ballroom Salon III - 7th Floor Introduction of CRWAD Officers and Dedicatee, Poster Session I Student Reception – Students and invited guests - 5:00 PM – 5:45PM, Salon II Room, 7th Floor Business Meeting - Chicago Ballroom A/B/C/D 5th Floor 11:45 AM - 12:30 PM Tuesday, December 10 Dedication of the meeting, Introduction of New Members, Grad Student Awards New member applicants and students entered in competition are invited and encouraged to attend. Speaker Ready Room is: Streeterville Room (2nd floor) - Sunday, Dec. 8 - Monday, Dec. 9 Marriott Hotel Monday AM Monday PM Tuesday AM 8:00 - 11:30 1:30 - 4:30 8:00 - 11:30 Section Room Room Room Abstract Nos. Abstracts Nos. Abstracts Nos. Bacterial Avenue Ballroom Avenue Ballroom Pathogenesis 001 – 008 009 – 019 Biosafety and Denver/Houston Biosecurity 020 – 026 Companion Animal Epidemiology Michigan/Michigan Michigan/Michigan State State 027 – 036 037 – 042 Ecology and Management Salon E Salon E of Foodborne Agents 043 – 052 079, 053 – 055 Epidemiology Salons A/B/C/D Salons A/B/C/D Salons A/B/C/D and Animal Health Economics 056 – 067 068 – 078 080 – 084 Immunology Salons F/G/H Salons F/G/H Salons F/G/H 085 – 091 092 – 099 100 - 109 Pathobiology of Enteric and Los Foodborne Pathogens Angeles/Miami 110 – 119 Respiratory Indiana/Iowa Indiana/Iowa Diseases 120 – 128 129 – 132 Vector-Borne and Denver/Houston Parasitic Diseases 133 – 139 Viral Los Angeles/Miami Los Angeles/Miami Pathogenesis 140 – 149 150 – 153 Posters* in Grand Ballroom Salon III-7th Floor Salon III-7th Floor Sun. 6:30 - 8 PM Mon. 5 - 6:30 PM *SUNDAY POSTER PRESENTERS: Poster boards will be available for poster assembly by 4 PM Sunday. Posters for the Bacterial Pathogenesis, Biosafety and Biosecurity, Companion Animal Epidemiology, Epidemiology and Animal Health Economics, Pathobiology of Enteric and Foodborne Pathogens, and Respiratory Diseases Sections will be presented Sunday from 6:30-8:00 PM. Please remove your posters by 10:00 AM Monday. *MONDAY POSTER PRESENTERS: Poster boards will be available for poster assembly by noon Monday. Posters for the Ecology and Management of Foodborne Agents, Immunology, Vector- Borne and Parasitic Diseases, and Virology Sections will be presented Monday from 5:00-6:30 PM. Please remove your posters immediately upon completion of Poster Session II, by 6:30 PM. Poster Presenters must be with their competition entry posters for possible judge interviews and must wear their name badge during their presentation. Poster Boards are 4 ft tall x 8 ft wide. Poster presenters must furnish their own tacks. Chicago Marriott, Floor Plan - 5th and 6th Floors i Chicago Marriott Floor Plan – 4th and 7th Floors Avenue Ballroom on 4th Floor ii COPYRIGHT © 2013 by Robert P. Ellis, Executive Director of the Conference of Research Workers in Animal Diseases (CRWAD), and by CRWAD. All rights reserved. No part of this book may be reproduced or transmitted in any form or any means, electronic or mechanical, including recording, photocopying or by information storage and retrieval system, without the written permission of the copyright owner. Program and Proceedings compiled and edited by L. Susanne Squires, CRWAD Administrative Assistant. Contact CRWAD Executive Director, Robert P. Ellis, for Distribution: CRWAD Dr. Robert P. Ellis, Executive Director Department of Microbiology, Immunology & Pathology Colorado State University, Bldg. 1682 Fort Collins, CO 80523-1682 Phone: 970-491-5740 Fax: 970-491-1815 E-Mail: [email protected] Printed in the United States of America ISBN 978-0-9800515-6-8 (ISBN-10 0-9800515-6-8) (softcover only) iii Table of Contents Page No. Summary Table – Sections’ Room Organizer inside of front cover Hotel Floor Plan i-ii Copyright iii Table of Contents iv CRWAD Meeting and Organization Information 1 Council Officers – Recent Past Presidents 2 Dedicatee Tradition - A List of Past Dedicatees 2 Dedicatee 2013 - Dr. Fredric W. Scott 3-4 Distinguished Veterinary Microbiologist Biography 5 Distinguished Veterinary Immunologist Biography 6 Graduate Student Awards Sponsors outside of back cover Mark Gearhart Memorial Graduate Student Award Abstract 7 In Memoriam 8-12 Sponsorships 14-15 Advertisements 16 Exhibitors and Product Descriptions 17 Keynote Speakers 18 Keynote Speaker Biographies 19-25 Satellite Meetings (schedules listed alphabetically) 26-28 Symposium - AVEPM - Schwabe Program 29-30 Titles Listed By The Hour and Day 31-41 Poster Sessions Information 31 Speaker Ready Room 31 Program - Posters listed by Sections 43-57 Program - Oral Presentations listed by Sections 59-85 ABSTRACTS Section Abstract No. Page No. Posters (All Sections) 001P – 094 P 87-116 Bacterial Pathogenesis 001 – 019 118-123 Biosafety and Biosecurity 020 – 026 123-125 Companion Animal Epidemiology 027 – 042 126-131 Ecology and Management of Foodborne Agents 043 – 055 131-135 Epidemiology and Animal Health Economics 056 – 084 135-144 Immunology 085 – 109 144-152 Pathobiology of Enteric and Foodborne Pathogens 110 – 119 152-155 Respiratory Diseases 120 – 132 155-159 Vector-Borne and Parasitic Diseases 133 – 139 159-161 Viral Pathogenesis 140 – 153 162-166 Index - Authors and Abstract Numbers 168-179 2014 CRWAD Meeting Information outside of back cover iv CRWAD Meeting and Organization Information The Conference of Research Workers in Animal Diseases (CRWAD) was founded in Chicago in 1920. The CRWAD Annual Meeting is held on a Sunday, Monday and Tuesday of December, and consists of oral and poster presentations. The presentations are arranged into the following 10 Sections, according to the primary topic of the presentation: Bacterial Pathogenesis, Biosafety and Biosecurity, Companion Animal Epidemiology, Ecology and Management of Foodborne Agents, Epidemiology and Animal Health Economics, Immunology, Pathobiology of Enteric and Foodborne Pathogens, Respiratory Diseases, Vector-Borne and Parasitic Diseases, and Viral Pathogenesis. The oral presentations are limited to 15 minutes, with a recommendation of ten minutes presentation and five minutes for discussion. There are usually seven or eight Sections meeting simultaneously, so the time limit is judiciously recognized in order to allow attendees to move from Section to Section to listen and discuss the presentations of most interest to them. The two general Poster Sessions are held Sunday evening and Monday afternoon. Attendance is limited to members, nonmembers who are member applicants or who are presenters at the meeting, and invited guests. The attendance has ranged from 500 to 550 for the past several years, with attendees from countries throughout the world. The PROCEEDINGS of the annual meeting are published each year. A limited number of PROCEEDINGS is available for the years prior to 1995 from the Executive Director. CRWAD distributes the Proceedings. Prospective members should be actively engaged in research or research administration. Meeting information and membership applications may be obtained by contacting the Executive Director or by visiting our web site. ABSTRACTS ARE AVAILABLE AT THE ON-LINE MEETING PLANNER AND ITINERARY BUILDER. http://www.cvmbs.colostate.edu/mip/crwad/ Purpose Statement The Conference of Research Workers in Animal Diseases (CRWAD) was established in 1920. CRWAD is a non-profit organization and has been so since its origin. The sole purpose of CRWAD is to discuss and disseminate the most current research advances in animal diseases. Graduate students and industry and academic professionals present and discuss the most recent advances on subjects of interest to the CRWAD and of importance to the global livestock and companion animal industries. The oral and poster abstracts of new and unpublished data presented at the meeting sessions are published each year in the CRWAD Proceedings. Dr. Robert P. Ellis, Executive Director Department of Microbiology, Immunology and Pathology College of Veterinary Medicine and Biomedical Sciences Colorado State University, Campus Stop 1682 Fort Collins, CO 80523-1682 Phone: 970-491-5740; Fax: 970-491-1815 E-mail: [email protected] CRWAD Web Page Address: http://www.cvmbs.colostate.edu/mip/crwad/ 1 2013 Officers President - Rodney A. Moxley Vice President - David A. Benfield Council Members - Roman R. Ganta (2009 – 2013); Laurel J. Gershwin (2010 – 2014); Paul S. Morley (2011 – 2015); Christopher Chase (2012 - 2016) Executive Director - Robert P. Ellis Administrative Assistant – L. Susanne (Suzy) Squires Recent Past Presidents Donald L. Reynolds – 2012 Laura L. Hungerford - 2011 Eileen L. Thacker – 2010 Bill Stich - 2009 Richard E. Isaacson - 2008 Lynn A. Joens - 2007 Prem Paul - 2006 Ian Gardner - 2005 Janet MacInnes - 2004 Katherine M. Kocan - 2003 Franklin A. Ahrens - 2002 Linda J. Saif - 2001 Leon N. D. Potgieter - 2000 M. D. Salman - 1999 Donald G. Simmons - 1998 Bert E. Stromberg - 1997 Patricia E. Shewen - 1996 Bradford B. Smith - 1995 Ronald D. Schultz - 1994 Lawrence H. Arp - 1993 Richard F. Ross - 1992 Robert M. Corwin - 1991 Lynette B. Corbeil - 1990 William C. Wagner - 1989 The Dedicatee Tradition Each year, we select a Life member who has made outstanding contributions to CRWAD and to animal disease research to be honored as the Dedicatee for the CRWAD Annual Meeting. This tradition was initiated in 1974. Each Dedicatee is invited to attend the Annual Meeting as our guest. At the Business Meeting, the meeting is formally dedicated to the Dedicatee and the Dedicatee is given a plaque and an honorarium.
Load more

Recommended publications
  • National Program Assessment, Animal Health: 2000-2004
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln U.S. Department of Agriculture: Agricultural Publications from USDA-ARS / UNL Faculty Research Service, Lincoln, Nebraska 10-5-2004 National Program Assessment, Animal Health: 2000-2004 Cyril G. Gay United States Department of Agriculture, Agricultural Research Service, National Program Staff, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/usdaarsfacpub Part of the Agriculture Commons, Animal Sciences Commons, and the Animal Studies Commons Gay, Cyril G., "National Program Assessment, Animal Health: 2000-2004" (2004). Publications from USDA- ARS / UNL Faculty. 1529. https://digitalcommons.unl.edu/usdaarsfacpub/1529 This Article is brought to you for free and open access by the U.S. Department of Agriculture: Agricultural Research Service, Lincoln, Nebraska at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Publications from USDA-ARS / UNL Faculty by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. U.S. government work. Not subject to copyright. National Program Assessment Animal Health 2000-2004 National Program Assessments are conducted every five-years through the organization of one or more workshop. Workshops allow the Agricultural Research Service (ARS) to periodically update the vision and rationale of each National Program and assess the relevancy, effectiveness, and responsiveness of ARS research. The National Program Staff (NPS) at ARS organizes National Program Workshops to facilitate the review and simultaneously provide an opportunity for customers, stakeholders, and partners to assess the progress made through the National Program and provide input for future modifications to the National Program or the National Program’s research agenda.
    [Show full text]
  • Help Protect Your Herd with the Total Package. Demonstrated Safety and Efficacy
    ENVIRACORTM J-5 | MASTITIS PREVENTION HELP PROTECT YOUR HERD WITH THE TOTAL PACKAGE. DEMONSTRATED SAFETY AND EFFICACY. ENVIRACORTM J-5 | MASTITIS PREVENTION Coliform mastitis. Frightening in its severity and frequent fatality. Well-managed herds that have effectively controlled contagious mastitis are especially at risk for coliform mastitis. It carries the greatest potential for losing a quarter or even the cow, in part 60 to 70 because of bacterial endotoxins. percent70 to 80 Escherichia coli can be found throughout a cow’s environment. Coliformpercent mastitis infections • Up to 53 percent of all coliform mastitis cases are caused by that become clinical1 environmental bacteria.4 • E. coli is the primary bacterium responsible.5 • Milk should be cultured to learn which bacteria are involved so a vaccination program can be targeted. Vaccination should be part of every E. coli mastitis management 50 percent program. E. coli mastitis infections While complete prevention of E. coli mastitis is impossible, established during the dry period that remain dormant vaccination with an E. coli vaccine will help lessen the severity of until shortly after freshening2 cases and help provide an opportunity for successful treatment. $378.13 Average cost of each case of clinical E. coli mastitis3 When coliform mastitis occurs, it can cause: • Fever • Abnormal milk • Lack of appetite • Excessive udder edema • Diarrhea • Dehydration • Dramatic drop in milk production • Death A total package of safety and demonstrated efficacy. ENVIRACORTM J-5 is the safe and effective way to help control clinical signs associated with E. coli mastitis. Efficacy = 2 ½ days shorter duration of E. coli mastitis.6 The three-dose regimen helps stimulate the immune system for optimum response to help fight clinicalE.
    [Show full text]
  • Breeding for Disease Resistance in Farm Animals, 3Rd Edition
    BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION Bishop_FM.indd i 10/12/2010 3:05:45 PM Bishop_FM.indd ii 10/12/2010 3:05:45 PM BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION Edited by Stephen C. Bishop The Roslin Institute and Royal (Dick) School of Veterinary Studies University of Edinburgh Midlothian, UK Roger F.E. Axford Formerly School of Agricultural and Forest Sciences University of Wales, Bangor UK Frank W. Nicholas Department of Animal Science University of Sydney Sydney, Australia and John B. Owen Formerly School of Agricultural and Forest Sciences University of Wales, Bangor UK Bishop_FM.indd iii 10/12/2010 3:05:45 PM CABI is a trading name of CAB International CABI Head Offi ce CABI North American Offi ce Nosworthy Way 875 Massachusetts Avenue Wallingford 7th Floor Oxfordshire OX10 8DE Cambridge, MA 02139 UK USA Tel: +44 (0)1491 832111 Tel: +1 617 395 4056 Fax: +44 (0)1491 833508 Fax: +1 617 354 6875 E-mail: [email protected] E-mail: [email protected] Website: www.cabi.org ©CAB International 2010. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronically, mechanically, by photocopying, recording or otherwise, without the prior permission of the copyright owners. A catalogue record for this book is available from the British Library, London, UK. Library of Congress Cataloging-in-Publication Data Breeding for disease resistance in farm animals/edited by Stephen C. Bishop [et al.]. -- 3rd ed. p. cm. Includes bibliographical references and index.
    [Show full text]
  • Mastitis Therapy and Pharmacology of Drugs in the Bovine Mammary Gland
    Mastitis Therapy and Pharmacology of Drugs in the Bovine Mammary Gland (Q) n 0 K. L. Anderson, D. V.M., Ph.D. '"'O '-< Department of Food Animal and Equine Medicine ......'"i and Surgery (JQg School of Veterinary Medicine > North Carolina State University 8 (D 4700 Hillsborough Street ......'"i (") Raleigh, NC 27606 § >00 Introduction 00 0 (")...... control field Mastitis remains a major concern of the dairy industry, TABLE 1. Elimination of infections during mastitis a...... despite frequent use of therapy and application of mastitis experiments. (Natzke and Everett, 1975). 0 ~ control programs. Prevention and control are the most Infections eliminated via o/o 0 productive approaches to mastitis. However, therapy is 1-i; 18 to important for clinical mastitis and is a component of Spontaneous recovery 0 Lactational therapy 27 < mastitis control. Approximately 20-80% of cows are affect­ 5· Dry period therapy 34 (D ed by clinical mastitis annually (Dohoo, 1987, Wilesmith et Culling 14 ~ al., 1986). The annual US market for intramammary infu­ Not eliminated 7 ~ (") sion products is approximately $30 million (Gingerich, ,-+-...... 100 ,-+-...... 1987). Mastitis therapy should be efficacious, cost-effective, 0 ~ and antibiotic residues in meat and milk should be avoided. The application of mastitis control has influenced mastitis (D '"i The purpose of this paper is to discuss mastitis therapy and prevalence and etiology. Mastitis due to Str. agalactiae has 00 0 the pharmacology of drugs in the bovine mammary gland. been markedly reduced, with less dramatic reductions for '"'O (D Specific areas considered include: St. aureus. The most significant change has been the relative ~ 1.
    [Show full text]
  • 2017 National Veterinary Scholars Symposium 18Th Annual August 4
    2017 National Veterinary Scholars Symposium 18th Annual August – 4 5, 2017 Natcher Conference Center, Building 45 National Institutes of Health Bethesda, Maryland Center for Cancer Research National Cancer Institute with The Association of American Veterinary Medical Colleges https://www.cancer.gov/ Table of Contents 2017 National Veterinary Scholars Symposium Program Booklet Welcome .............................................................................................................................. 1 NIH Bethesda Campus Visitor Information and Maps .........................................................2 History of the National Institutes of Health ......................................................................... 4 Sponsors ............................................................................................................................... 5 Symposium Agenda .......................................................................................................6 Bios of Speakers ................................................................................................................. 12 Bios of Award Presenters and Recipients ........................................................................... 27 Training Opportunities at the NIH ...................................................................................... 34 Abstracts Listed Alphabetically .......................................................................................... 41 Symposium Participants by College of Veterinary Medicine
    [Show full text]
  • Susceptibility to Mastitis : a Review of Factors Related to the Cow B
    SUSCEPTIBILITY TO MASTITIS : A REVIEW OF FACTORS RELATED TO THE COW B. Poutrel To cite this version: B. Poutrel. SUSCEPTIBILITY TO MASTITIS : A REVIEW OF FACTORS RELATED TO THE COW. Annales de Recherches Vétérinaires, INRA Editions, 1982, 13 (1), pp.85-99. hal-00901361 HAL Id: hal-00901361 https://hal.archives-ouvertes.fr/hal-00901361 Submitted on 1 Jan 1982 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. SUSCEPTIBILITY TO MASTITIS : A REVIEW OF FACTORS RELATED TO THE COW B. POUTREL Institut National de la Recherche Agronomique, Station de Pathologie de la Reproduction, 37380 Nouzilly, France LA SENSIBILITÉ AUX MAMMITES : REVUE DES FACTEURS LIÉS A LA VACHE Facteurs de sensibilité ou de résistance Factors of susceptibility or resistance aux infections mammaires to mammary infections 1. Sensibilité aux infections liée à des caractéristiques 1. Physiological factors of the cow influencing suscepti- physiologiques de la vache bility to infection 1.1. Nombre et stade de lactation 1.1. Age and stage of lactation 1.2. Production, facilité et vitesse de traite 1.2. Milk yield, ease and milking rate 2. Sensibilité aux infections liée à des caractéristiques morphologiques de la mamelle et du trayon 2.
    [Show full text]
  • Dairy Cattle Mastitis in and Around Sebeta, Ethiopia
    Dairy Cattle Mastitis In and Around Sebeta, Ethiopia Hunderra Sori, DVM, MS1 Ademe Zerihun, DVM, MS, PhD2 Sintayehu Abdicho, DVM, MS3 1National Veterinary Institute Debrezeit, Ethiopia 2Faculty of Veterinary Medicine Debrezeit, Ethiopia 3National Animal Disease Research Center Sebeta, Ethiopia KEY WORDS: cattle, dairy, mastitis, ing number of functional quarters). The Sebeta, Ethiopia infection rate showed statistically significant difference between the lactating quarters ABSTRACT and non-lactating quarters (P < 0.01). The A total of 180 local and crossbred dairy infection rate also varied significantly (P < cows were examined to determine the over- 0.05) between crossbred (56.29%) and local all prevalence of mastitis in and around zebu (34.48%). The prevalence of mastitis Sebeta using Californian Mastitis Test also significantly differed between animals (CMT), which revealed the overall mastitis with teat lesion, teat end shape, and status of prevalence in the area as 52.78% (16.11% ventilation (P < 0.01), udder conformation clinical and 36.67% sub-clinical cases). Of (P < 0.05), type of management (P < 0.01), 134 bacterial isolates identified from CMT- and frequency of barn cleaning (P < 0.01). positive samples sent to a laboratory for In 53.13% of animals sampled and 31.68% microbiological examination, the majority of CMT-positive quarters, mixed infection of isolates were Staphylococcus aureus per animal and per quarter was observed. (44.03%) followed by Staphylococcus epi- d e r m i d i s (14.93%) and M i c r o c o c c u s s p e c i e s INTRODUCTION (6.72%), and lowest isolation rate was for Mastitis has been known to cause a great Escherichia coli and Pseudomonas aerugi- deal of loss or reduction of productivity, to nosa (0.75% each).
    [Show full text]
  • Mycoplasma Mastitis in Dairy Cows
    Mycoplasma Mastitis Can you Control it on Your Farm? Pamela Ruegg, DVM, MPVM Introduction Mastitis is a well-recognized and costly disease of dairy cattle. Most farmers are well acquainted with traditional causes of mastitis such as Staphylococcus aureus and Streptococcus agalactia. The widespread adoption of standard mastitis control practices such as teat dipping, dry cow therapy, appropriate treatment, judicious culling and good milking preparation has allowed many dairy farmers to control contagious forms of mastitis. In a recent study, Staph aureus and Strep ag accounted for only 8% of clinical mastitis cases in Ontario dairy herds.4 While these traditional forms of mastitis are now controllable, mastitis continues to require management attention Other organisms have emerged to fill the niche created by the control of contagious Fig 2: Mycoplasma Diagnosis in Wisconsin Fig 3: Mycoplasma Diagnosis in New York 60 60 50 50 40 40 30 30 20 20 Number of Herds Number of Herds 10 10 0 0 1992 1993 1994 1995 1996 1997 1998 1989 1990 1991 1992 1993 1994 organisms. An organism that is increasingly isolated from clinical mastitis in Wisconsin is Mycoplasma bovis (Fig 2). Prior to 1992, there were only 2 confirmed herd outbreaks within Wisconsin, between 1992 and 1998 at least 140 herd outbreaks of that organism were reported.5 A similar trend has been reported from dairies in New York (Fig 3).2 Mycoplasma mastitis was once considered to be a disease of large western dairy herds. In recent years it has become recognized in Midwest and Northeastern dairy regions. This presentation will review basic facts about mastitis caused by mycoplasma and discuss control strategies to minimize the risk of an outbreak.
    [Show full text]
  • Factors Associated with Intramammary Infection in Dairy Cows Caused By
    J. Dairy Sci. 100:493–503 https://doi.org/10.3168/jds.2016-11465 © 2017, THE AUTHORS. Published by FASS and Elsevier Inc. on behalf of the American Dairy Science Association®. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). Factors associated with intramammary infection in dairy cows caused by coagulase-negative staphylococci, Staphylococcus aureus, Streptococcus uberis, Streptococcus dysgalactiae, Corynebacterium bovis, or Escherichia coli S. Taponen,*1 E. Liski,† A.-M. Heikkilä,† and S. Pyörälä* *Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Paroninkula 20, FI-04920 Saarentaus, Finland †Natural Resources Institute Finland, Viikinkaari 4, FI-00790 Helsinki, Finland ABSTRACT barns with parlor milking had an increased probability of contracting an IMI compared with cows in tiestall The aim of this study was to determine risk factors barns or in new freestall barns with automatic milking. for bovine intramammary infection (IMI) associated This was the case for all IMI, except those caused by with the most common bacterial species in Finland. CNS, the prevalence of which was not associated with Large databases of the Finnish milk-recording system the milking system, and IMI caused by Staph. aureus, and results of microbiological analyses of mastitic which was most common in cows housed in tiestall milk samples from Valio Ltd. (Helsinki, Finland) were barns. A better breeding index for milk somatic cell analyzed. The study group comprised 29,969 cows with count was associated with decreased occurrence of IMI, IMI from 4,173 dairy herds.
    [Show full text]
  • Enhancing Drug Efficacy Against Mastitis Pathogens—An in Vitro
    animals Article Enhancing Drug Efficacy against Mastitis Pathogens—An In Vitro Pilot Study in Staphylococcus aureus and Staphylococcus epidermidis Karthic Rajamanickam 1 , Jian Yang 1, Saravana Babu Chidambaram 2 and Meena Kishore Sakharkar 1,* 1 College of Pharmacy and Nutrition, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada; [email protected] (K.R.); [email protected] (J.Y.) 2 Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research (JSS AHER), Mysuru-570015, Karnataka, India; [email protected] * Correspondence: [email protected] Received: 5 October 2020; Accepted: 9 November 2020; Published: 15 November 2020 Simple Summary: The success rate of antibiotic treatment of mastitis is highly variable. Concurrently, the efficacy of available antibiotics is compromised by the rapid emergence of drug-resistant bacteria. Recently, it was reported that there has been a reduction in the presence of antibiotic-resistant bacteria in food-producing animals where interventions provide for restrictions in antibiotic use. In addition, societal concerns regarding the use of antimicrobials in food animal production are putting increasing pressure on all aspects of livestock production. Here, we have conducted a systematic procedure for the identification of conserved and unique drug targets. We propose that combination therapy with drugs that work synergistically against conserved and unique targets can help increase efficacy and lower the usage of antibiotics for treating bacterial infections. An in vitro pilot validation of our findings in vitro for the two most common mastitis-causing bacteria in North America—Staphylococcus aureus and the coagulase-negative Staphylococcus epidermidis—is presented.
    [Show full text]
  • WELFARE ISSUES RELATED to MASTITIS in DAIRY COWS E
    Nº 10 / SEPTEMBER 2014 www.fawec.org THE farm ANIMAL welfare fact SHEET WELFARE ISSUES RELATED TO MASTITIS IN DAIRY COWS E. MAINAU, D. TEMPLE, X. MANTECA Mastitis is one of the major animal welfare and economic problems in dairy cattle production. Although in recent years there has been a general decline in the incidence of mastitis, high incidences such as 25-45% are still being currently reported. Mastitis is a multifactorial disease in which the environment, the pathogens and the host (cow) interact with each other. MASTITIS CAUSES PRODUCTION AND ECONOMIC LOSSES is a well-organised adaptive response of the animal to enhance di- sease resistance and recovery from disease. Pain caused by masti- Mastitis is one of the most costly diseases affecting dairy cattle. Di- tis may modify the expression of sickness behaviour. In particu- rect economic costs associated with mastitis include reduced milk lar, although lying time is usually increased during illness and it is yield and quality, increased veterinary costs, discarded milk (during thought to help the animal to save energy, cows with mastitis show the course of treatment) and somatic cell count (SCC) penalties. a reduction in lying time due to udder pain and this has important The main indirect costs, which are usually underestimated by far- negative effects on their welfare and production. It must not be mers, are the increased risk of culling and reduced fertility. On ave- underestimated that resting is a very important behaviour for dairy rage, each case of clinical mastitis causes an estimated loss of around cattle; healthy cows typically spend approximately 12-13 hours per 200 Euros.
    [Show full text]
  • An Update on Environmental Mastitis: Challenging Perceptions
    Received: 13 April 2017 DOI: 10.1111/tbed.12704 DISCONTOOLS SUPPLEMENT An update on environmental mastitis: Challenging perceptions I. C. Klaas1 | R. N. Zadoks2,3 1Department of Veterinary and Animal Sciences, Faculty of Health and Medical Summary Sciences, University of Copenhagen, Environmental mastitis is the most common and costly form of mastitis in modern Frederiksberg C, Denmark dairy herds where contagious transmission of intramammary pathogens is controlled 2Moredun Research Institute, Penicuik,UK 3Institute of Biodiversity, Animal Health and through implementation of standard mastitis prevention programmes. Environmental Comparative Medicine, College of Medical, mastitis can be caused by a wide range of bacterial species, and binary classification Veterinary and Life Sciences, University of Glasgow, Glasgow, UK of species as contagious or environmental is misleading, particularly for Staphylococ- cus aureus, Streptococcus uberis and other streptococcal species, including Streptococ- Correspondence R. N. Zadoks, Institute of Biodiversity Animal cus agalactiae. Bovine faeces, the indoor environment and used pasture are major Health and Comparative Medicine, sources of mastitis pathogens, including Escherichia coli and S. uberis. A faeco-oral University of Glasgow, UK. Email: [email protected] transmission cycle may perpetuate and amplify the presence of such pathogens, including Klebsiella pneumoniae and S. agalactiae. Because of societal pressure to reduce reliance on antimicrobials as tools for mastitis control, management of envi- ronmental mastitis will increasingly need to be based on prevention. This requires a reduction in environmental exposure through bedding, pasture and pre-milking man- agement and enhancement of the host response to bacterial challenge. Efficacious vaccines are available to reduce the impact of coliform mastitis, but vaccine devel- opment for gram-positive mastitis has not progressed beyond the “promising” stage for decades.
    [Show full text]